{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:51:37Z","timestamp":1774493497609,"version":"3.50.1"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T00:00:00Z","timestamp":1484179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0170070","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T18:44:32Z","timestamp":1484246672000},"page":"e0170070","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cutaneous Deficiency of Filaggrin and STAT3 Exacerbates Vaccinia Disease In Vivo"],"prefix":"10.1371","volume":"12","author":[{"given":"Yong","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishrat","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyo","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,1,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jaci.2009.05.002","article-title":"Inhibition of S100A11 gene expression impairs keratinocyte response against vaccinia virus through downregulation of the IL-10 receptor 2 chain","volume":"124","author":"L Bin","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/cid\/cir952","article-title":"Eczema vaccinatum","volume":"54","author":"JL Reed","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"SM Holland","year":"2007","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e113690","DOI":"10.1371\/journal.pone.0113690","article-title":"Vaccinia virus induces rapid necrosis in keratinocytes by a STAT3-dependent mechanism","volume":"9","author":"Y He","year":"2014","journal-title":"PLoS ONE"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/jid.2011.435","article-title":"Skin barrier disruption- a requirement for allergen sensitization?","volume":"132","author":"A De Benedetto","year":"2012","journal-title":"J Invest Dermatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1242\/jcs.033969","article-title":"Filaggrin in the frontline: role in skin barrier function and disease","volume":"122","author":"A Sandilands","year":"2009","journal-title":"J Cell Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"CN Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3851\/IMP1734","article-title":"Topical treatment of cutaneous vaccinia virus infections in immunosuppressed hairless mice with selected antiviral substances","volume":"21","author":"DF Smee","year":"2011","journal-title":"Antivir Chem Chemother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ng.358","article-title":"A homozygous frameshift mutation in the mous Flg gene facilitates enhanced percutaneous allergen priming","volume":"401","author":"PG Fallon","year":"2009","journal-title":"Nat Genet"},{"key":"ref10","article-title":"Epidermal filaggrin deficiency mediates increased systemic TH17 immune response","author":"CM Bonefield","year":"2016","journal-title":"Br J Deramtol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1128\/CVI.00280-10","article-title":"Postexposure prevention of progressive vaccinia in SCID mice treated with vaccinia immune globulin","volume":"18","author":"RW Fisher","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.4049\/jimmunol.151.8.4266","article-title":"Induction by IL-9 and suppression by IL-3 and IL-4 of the levels of chromosome 14-derived transcripts that encode late-expressed mast cell proteases","volume":"151","author":"KK Eklund","year":"1993","journal-title":"J Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1189\/jlb.0103012","article-title":"Role of activin A in murine mast cells: modulation of cell growth, differentiation, and migration","volume":"73","author":"M Funaba","year":"2003","journal-title":"J Leukoc Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2014-4318","article-title":"Role of Activin A and myostatin in human cancer cachexia","volume":"100","author":"A Loumaye","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1126\/science.8140412","article-title":"Characterization of type I receptors for transforming growth factor-\u03b2 and activin","volume":"264","author":"P Ten Dijke","year":"1994","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1016\/j.jaci.2009.07.013","article-title":"Filaggrin in atopic dermatitis","volume":"124","author":"GM O\u2019Regan","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl.1","key":"ref17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1396-0296.2004.04S1005.x","article-title":"Moisturization and skin barrier function","volume":"17","author":"AV Rawlings","year":"2004","journal-title":"Dermatol Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ceb.2012.10.018","article-title":"The expanding significance of keratin intermediate filaments in normal and diseased epithelia","volume":"25","author":"X Pan","year":"2013","journal-title":"Curr Opin Cell Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1038\/ncomms7574","article-title":"Vimentin regulates activation of the NLRP3 inflammasome","volume":"6","author":"G dos Santos","year":"2015","journal-title":"Nat Commun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1006\/dbio.1996.0042","article-title":"Strong induction of activin expression after injury suggests an important role of activin in wound repair","volume":"173","author":"G Hubner","year":"1996","journal-title":"Dev Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.4049\/jimmunol.1301350","article-title":"Mast cells are dispensable for normal and activin-promoted wound healing and skin carcinogenesis","volume":"191","author":"M Antsiferova","year":"2013","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1089\/scd.2015.0377","article-title":"Development of antiviral innate immunity during in vitro differentiation of mouse embryonic stem cells","volume":"25","author":"W D\u2019Angelo","year":"2016","journal-title":"Stem Cells Dev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4049\/jimmunol.1101703","article-title":"Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides","volume":"188","author":"Z Wang","year":"2012","journal-title":"J Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0170070","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T18:26:33Z","timestamp":1692642393000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0170070"}},"subtitle":[],"editor":[{"given":"Miroslav","family":"Blumenberg","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,12]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0170070","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,12]]}}}